These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Treatment of chronic ventricular dysrhythmias with a new drug: aprindine (AC 1802). Van Durme JP; Rousseau M; Mbuyamba P Acta Cardiol; 1974; Suppl 18():335-40. PubMed ID: 4138863 [No Abstract] [Full Text] [Related]
7. [Anti-arrhythmic efficacy of aprindine during the acute phase of myocardial infarct]. Hagemeijer F; Janse C; Hugenholtz PG Acta Cardiol; 1974; Suppl 18():409-21. PubMed ID: 4138502 [No Abstract] [Full Text] [Related]
8. The pharmacology and clinical evaluation of aprindine a new antiarrhythmic agent. Fasola AF; Carmichael R Acta Cardiol; 1974; Suppl 18():317-33. PubMed ID: 4138741 [No Abstract] [Full Text] [Related]
9. [Comparison of aprindine (AC 1802) and lidocaine by intravenous route during the acute phase of myocardial infarct]. Depaepe A; Bohyn P; De Maertelaere M; Dernier J; Cloetens W; De Mey D Acta Cardiol; 1974; Suppl 18():423-32. PubMed ID: 4138738 [No Abstract] [Full Text] [Related]
10. Aprindine (AC 1802), a new anti-arrhythmic drug. Kesteloot H; Van Mieghem W; De Geest H Acta Cardiol; 1973; 28(2):145-65. PubMed ID: 4121909 [No Abstract] [Full Text] [Related]
11. [Effects of aprindine in disorders of the auriculoventricular conduction]. Petit-Guinovart M; Ballesta-Barcons F Acta Cardiol; 1974; Suppl 18():369-87. PubMed ID: 4547427 [No Abstract] [Full Text] [Related]
12. [Clinical experiences with a new orally effective antiarrhythmic agent (Aprindin)]. Breithardt G; Gleichmann U; Seipel L; Loogen F Z Kardiol; 1974 May; 63(3):435-44. PubMed ID: 4608660 [No Abstract] [Full Text] [Related]
13. Lidocaine as an antiarrhythmic Experience in 68 patients. Flensted-Jensen E; Sandoe E Acta Med Scand; 1969 Apr; 185(4):297-302. PubMed ID: 4185142 [No Abstract] [Full Text] [Related]
14. Therapeutic effectiveness and plasma levels of aprindine, a new antidysrhythmic drug. Van Durme JP; Bogaert MG; Rosseel MT Eur J Clin Pharmacol; 1974 Aug; 7(5):343-6. PubMed ID: 4607575 [No Abstract] [Full Text] [Related]
15. Therapeutic effectiveness and plasma levels of a new antidysrhythmic drug: aprindine. Van Durme JP; Rosseel T; Bogaert M Acta Cardiol; 1974; Suppl 18():233-4. PubMed ID: 4138126 [No Abstract] [Full Text] [Related]
16. [Panel discussion: Evaluation of the antiarrhythmic drugs and current problems associated with their use in clinical practice (author's transl)]. Acta Cardiol; 1974; Suppl 18():441-58. PubMed ID: 4138236 [No Abstract] [Full Text] [Related]
17. [What is safe in the therapy of tachycardic heart arrhythmias?]. Wehr M; Noll B; Krappe J Internist (Berl); 1985 Dec; 26(12):741-9. PubMed ID: 2417980 [No Abstract] [Full Text] [Related]
18. Practolol in the treatment of cardiac dysrhythmias due to acute myocardial infarction. Jewitt DE; Mercer CJ; Shillingford JP Lancet; 1969 Aug; 2(7614):227-30. PubMed ID: 4184104 [No Abstract] [Full Text] [Related]
19. [Treatment of extrasystoles using a new oral anti-arrhythmic agent Aprindine]. Sterz H Acta Med Austriaca; 1974; 1(4):127-31. PubMed ID: 4142916 [No Abstract] [Full Text] [Related]
20. Treatment of recurrent ventricular tachycardia and fibrillation with aprindine. Fasola AF; Noble RJ; Zipes DP Am J Cardiol; 1977 May; 39(6):903-9. PubMed ID: 67800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]